Sign in

Jonathan Rittmo

@jorittmo.bsky.social
31 followers 36 following 28 posts

Failed poet. Neuroimaging, statistics, Alzheimer's and aging. Optimizing the rng seed.

PostsRepliesMedia
Jonathan Rittmo @jorittmo.bsky.social · 6h
The first paper from my PhD is out in Nature Neuroscience! Aging and Alzheimer's disease reshape how the brain communicates. But not in the same way: aging vs AD related alterations follow two distinct axes of brain organization Paper → www.nature.com/articles/s41... #Alzheimers #Neuroimaging 🧵⬇️
120
Reposted by Jonathan Rittmo
biofinder.bsky.social @biofinder.bsky.social · 08/04/2026
New publication out in Brain! 📢We developed a data-driven multimodal biomarker framework to characterize a memory clinic cohort based on the presence, extent, and sequence of common pathologies. This framework may support diagnosis and trial selection. 🔗https://doi.org/10.1093/brain/awaf411
122
Reposted by Jonathan Rittmo
Jake Vogel @jwvogel.bsky.social · 16/03/2026
Going to ADPD? Come see our work! We would love to share it with you and chat about it if you are interested. See below for a schedule of our sessions, which cover fMRI, proteomics, transcriptomics and AI, led by brilliant lab members @anlijuncn.bsky.social @jorittmo.bsky.social and others
073
Reposted by Jonathan Rittmo
Lijun An @anlijuncn.bsky.social · 15/07/2025
Can AI reveal risk & co-pathology of multiple neurodegenerative diseases from a single blood sample? We explored AI-based diagnostic power on high rank plasma proteomics (N=17,170). www.medrxiv.org/content/10.1... #neuroskyence #neurosky #Alzheimer #compneuro #AI #datascience #neurology
medrxiv.org
Benchmarking the AI-based diagnostic potential of plasma proteomics for neurodegenerative disease in 17,170 people
Co-pathology is a common feature of neurodegenerative diseases that complicates diagnosis, treatment and clinical management. However, sensitive, specific and scalable biomarkers for in vivo pathologi...
1115
Jonathan Rittmo @jorittmo.bsky.social · 27/05/2025
How does the brain reorganize in the context of age and AD? Are functional changes in age and AD similar? Are these changes dynamic across the age/AD spectrum? We unpack these questions in a sample of N=973 with AD biomarkers Preprint: tinyurl.com/ymv8s7h8 ⬇️🧵 1/
32010
Reposted by Jonathan Rittmo
biofinder.bsky.social @biofinder.bsky.social · 25/04/2025
‼️New preprint! We are happy to share our latest work led by @teanijarv.bsky.social investigating why tau pathology in AD often accumulates more in one hemisphere of the brain than the other. Check out 🔗https://biorxiv.org/content/10.1101/2025.04.15.648728v1 or dive into the details below👇
144
Jonathan Rittmo @jorittmo.bsky.social · 28/04/2025
Really important and cool work by @xiaoyucaly.bsky.social! Congratulations!
011